Search details
1.
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.
Gynecol Oncol
; 159(1): 142-149, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32763109
2.
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer.
Breast Cancer Res Treat
; 160(1): 91-99, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27654971
3.
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Lancet Oncol
; 16(7): 816-29, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-26092818
4.
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.
Lancet Oncol
; 15(10): 1137-46, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-25130998
5.
Cancer care in South Africa.
Lancet Oncol
; 13(8): e324, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22846830
6.
Ipilimumab in Pretreated Patients With Advanced Malignant Melanoma: Results of the South African Expanded-Access Program.
J Glob Oncol
; 3(5): 515-523, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-29094091
7.
Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvement.
J Multidiscip Healthc
; 8: 335-44, 2015.
Article
in English
| MEDLINE | ID: mdl-26251610
8.
A postauthorization survey to document the therapeutic management of oxaliplatin as a first-line chemotherapy regimen in South Africa in patients with metastatic colorectal cancer.
Chemother Res Pract
; 2014: 520701, 2014.
Article
in English
| MEDLINE | ID: mdl-24818022
9.
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: analysis from the NeoALTTO trial.
J Clin Oncol
; 31(36): 4504-11, 2013 12 20.
Article
in English
| MEDLINE | ID: mdl-24248687
Results
1 -
9
de 9
1
Next >
>>